Search
+
    SEARCHED FOR:

    OBESITY PILL

    Ozempic frenzy lures rich Indians to brave the gray market

    People are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying counterfeit formulas online, and importing boxes from Europe. The treatments have sparked extensive media coverage, fueling a high demand. According to Goldman Sachs Research, the anti-obesity medication market could hit $100 billion by 2030. In contrast, Indians have largely been observers in this global frenzy over the new weight-loss solutions.

    New oral diabetes + obesity drug's India sales surge 100%

    India experiences a surge in Rybelsus sales, impacting the anti-obesity market. Semaglutide dominates, reflecting India's obesity challenges and evolving disease patterns as it grows as a superpower.

    Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot

    Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in generic supply. The Bengaluru-based company secured UK approval for the first generic version of liraglutide injectible, positioning itself as a leader in this evolving market.

    Eli Lilly in advanced clinical trials for its weight-loss pill

    Eli Lilly has commenced phase three clinical trials in India for a new oral weight-loss drug called orforglipron. The trials aim to assess its safety and efficacy compared to insulin glargine in individuals with Type 2 diabetes and obesity or overweight at an increased cardiovascular risk. The company's spokesperson in India mentioned ongoing clinical studies on novel products, including orforglipron.

    Say goodbye to needle pricks! A daily pill may be cure to world's obesity problem

    Novo Nordisk's weight-loss drug, Wegovy, which has so far only been available as an injection, may soon come in pill form. Clinical trials showed that high-dose oral versions of the medication worked almost as well as the injections in paring pounds and improving health.

    Diabetes drug may be the pill for long Covid

    Taking the diabetes drug metformin within three days of testing positive for Covid-19 may reduce the risk of developing long Covid by 40%, according to a study. The US trial, reported in the Lancet, involved 1,126 overweight and obese patients, 35 of whom were diagnosed with enduring symptoms after taking metformin versus 58 on a placebo. The study did not assess the impact of the drug on those already suffering from long Covid.

    The Economic Times
    BACK TO TOP